Federated Hermes Inc. Raises Stock Position in Maximus, Inc. $MMS

Federated Hermes Inc. increased its position in shares of Maximus, Inc. (NYSE:MMS) by 1.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 688,505 shares of the health services provider’s stock after acquiring an additional 8,847 shares during the period. Federated Hermes Inc.’s holdings in Maximus were worth $62,909,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC increased its holdings in shares of Maximus by 9.3% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 9,407 shares of the health services provider’s stock worth $860,000 after purchasing an additional 800 shares during the period. Cullen Frost Bankers Inc. bought a new stake in Maximus during the third quarter valued at $38,000. Retirement Systems of Alabama grew its position in Maximus by 48.1% during the third quarter. Retirement Systems of Alabama now owns 102,030 shares of the health services provider’s stock worth $9,322,000 after buying an additional 33,159 shares in the last quarter. Resona Asset Management Co. Ltd. increased its stake in Maximus by 5.7% in the 3rd quarter. Resona Asset Management Co. Ltd. now owns 5,369 shares of the health services provider’s stock worth $491,000 after acquiring an additional 289 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp raised its holdings in shares of Maximus by 8.5% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 25,437 shares of the health services provider’s stock valued at $2,324,000 after acquiring an additional 1,999 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Stock Down 0.6%

Shares of MMS opened at $94.23 on Friday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $100.00. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a 50 day simple moving average of $89.87 and a two-hundred day simple moving average of $85.68. The firm has a market cap of $5.14 billion, a P/E ratio of 16.95 and a beta of 0.56.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the previous year, the firm posted $1.46 earnings per share. The company’s revenue was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a dividend of $0.33 per share. The ex-dividend date is Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a yield of 1.4%. Maximus’s dividend payout ratio (DPR) is currently 21.58%.

Insider Activity

In other news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total value of $350,746.76. Following the transaction, the insider owned 19,542 shares in the company, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Strong Buy”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.